CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Patel Snehal CEO and CFO | Purchase | +12,700 | $11.07 | $141K | 5,325,377 |
| 2023-11-10 | Patel Snehal CEO and CFO | Purchase | +5,000 | $10.17 | $51K | 5,312,677 |
| 2023-11-03 | Patel Snehal CEO and CFO | Purchase | +3,500 | $9.11 | $32K | 5,307,677 |
| 2023-10-27 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +500 | $8.57 | $4K | 260,348 |
| 2023-10-26 | Patel Snehal CEO and CFO | Purchase | +2,500 | $7.97 | $20K | 5,304,177 |
| 2023-10-25 | Patel Snehal CEO and CFO | Purchase | +2,500 | $7.91 | $20K | 5,301,677 |
| 2023-10-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.07 | $9K | 5,299,177 |
| 2023-10-04 | Patel Snehal CEO and CFO | Purchase | +2,000 | $8.63 | $17K | 5,298,177 |
| 2023-09-26 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +600 | $8.71 | $5K | 259,848 |
| 2023-09-19 | Patel Snehal CEO and CFO | Purchase | +4,000 | $8.95 | $36K | 5,296,177 |
| 2023-09-11 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.48 | $9K | 5,292,177 |
| 2023-08-22 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.97 | $10K | 5,291,177 |
| 2023-08-04 | Patel Snehal CEO and CFO | Purchase | +2,000 | $10.55 | $21K | 5,290,177 |
| 2023-07-21 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.20 | $9K | 5,288,177 |
| 2023-07-13 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $9.49 | $2K | 259,248 |
| 2023-05-17 | Patel Snehal CEO and CFO | Purchase | +1,000 | $11.69 | $12K | 5,287,177 |
| 2023-04-28 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $11.22 | $3K | 258,998 |
| 2023-04-19 | Patel Snehal CEO and CFO | Purchase | +7,000 | $11.10 | $78K | 5,286,177 |
| 2023-04-18 | Patel Snehal CEO and CFO | Purchase | +2,000 | $11.12 | $22K | 5,279,177 |
| 2023-04-11 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +1,000 | $11.87 | $12K | 258,745 |
Page 3 of 7 · 122 trades